Project Details
Projekt Print View

TRR 167:  Development, function and potential of myeloid cells in the central nervous system (NeuroMac)

Subject Area Medicine
Term since 2017
Website Homepage
Project identifier Deutsche Forschungsgemeinschaft (DFG) - Project number 259373024
 
Myeloid cells in the central nervous system (CNS) represent a heterogeneous class of innate immunecells that differentially contribute to the maintenance of tissue homeostasis during development,adulthood and disease. Recent studies using cell-specific targeting, in vivo imaging, single-cellexpression analysis and other sophisticated tools fundamentally changed our views on the origin, fateand function of distinct myeloid subsets in the CNS.In the first funding period, we have made substantial research efforts to elucidate the role of myeloidcells including microglia during brain diseases with a special focus on myeloid cell heterogeneity.Members of the CRC/TRR167 NeuroMac consortium introduced novel single-cell technologies inthe field of neuroimmunology such as single-cell RNA-sequencing (scRNA-Seq), single-cellsequencing assay for transposase-accessible chromatin-sequencing (scATAC-seq), single-cell massspectrometry (cytometry by time-of-flight [CyTOF]), which allowed us to characterize for the first timehuman microglia and discover targetable disease-linked microglia states.In the second funding period, we would like to draw on the resources of the first funding period. Indetail, we plan to determine the molecular mechanisms that govern myeloid cell identity, and focus onthe interactions of CNS myeloid cells with neurons and macroglia, which are essential to establishcontext-associated microglia states. The newly identified microglia clusters will now be spatiallymapped in brain pathologies using cutting-edge spatial genomic and proteomic tools. We shall alsouse newly developed transgenic mouse models for fate mapping and gene targeting to interfere withmyeloid cells functions.The long-term goal of the NeuroMac consortium is to facilitate the transfer of knowledge obtained frombasic research on brain myeloid cells to the improvement of patient care by providing sufficientpreclinical evidence for later 'bench-to-bedside' translation and by deciphering the fundamentalmechanisms of myeloid cell biology in the CNS during health and disease. In order to achieve thisambitious long-term goal, we need to provide more scientific basis by deciphering the fundamentalmechanisms of myeloid cell biology in the CNS during health and disease.
DFG Programme CRC/Transregios
International Connection Israel, USA

Current projects

Completed projects

Applicant Institution Albert-Ludwigs-Universität Freiburg
 
 

Additional Information

Textvergrößerung und Kontrastanpassung